Lyra Therapeutics Inc.
(LYRA)
undefined
undefined%
At close: undefined
0.18
0.22%
After-hours Dec 13, 2024, 07:41 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -1.04 | -0.43 | -0.33 | -1.11 | -3.73 | -4.82 |
| PS Ratio | 41.88 | 17.41 | 49.67 | 0.00 | 0.00 | 23.37 |
| PB Ratio | 0.73 | 0.29 | 0.41 | 0.33 | 8.18 | -0.27 |
| P/FCF Ratio | -1.01 | -0.55 | -0.48 | -1.07 | -4.29 | -4.35 |
| P/OCF Ratio | -1.03 | -0.55 | -0.55 | -1.16 | -4.36 | -4.38 |
| OCF/S Ratio | -10.16 | -7.96 | -22.65 | 0.00 | 0.00 | -1.33 |
| Debt / Equity Ratio | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Quick Ratio | 1.34 | 1.74 | 0.66 | 3.89 | 0.49 | 3.18 |
| Current Ratio | 1.34 | 1.74 | 0.66 | 3.89 | 0.49 | 3.18 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.05 |
| Interest Coverage | 0.00 | -26.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Equity (ROE) | -70.10% | -68.45% | -123.59% | -29.59% | -219.61% | 5.63% |
| Return on Assets (ROA) | -43.96% | -50.27% | -77.30% | -27.27% | -107.55% | -23.77% |
| Return on Capital (ROIC) | -54.57% | -58.96% | -119.10% | -29.24% | -169.34% | -31.02% |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Profit Margin | 25.00% | 5.43% | -62.81% | 0.00% | 0.00% | 25.00% |
| Net Profit Margin | -1005.78% | -1013.90% | -3720.18% | 0.00% | 0.00% | -121.16% |